Intentar ORO - Gratis
Govt Extends Due Date for Schedule M
Mint Chennai
|February 13, 2025
The government on Wednesday extended the due date for implementation of revised Schedule M—good manufacturing practices provision, for small and medium pharmaceutical firms with turnover of ₹250 crore or less, till the end of this year.
The ministry of health and family welfare has given three months from 11 February 2025, to the small and medium pharmaceutical firms to submit their plan for upgradation to the central license
Esta historia es de la edición February 13, 2025 de Mint Chennai.
Suscríbete a Magzter GOLD para acceder a miles de historias premium seleccionadas y a más de 9000 revistas y periódicos.
¿Ya eres suscriptor? Iniciar sesión
MÁS HISTORIAS DE Mint Chennai
Mint Chennai
Small-town wealthy dive into high-risk PMS schemes
Sophisticated, high-risk investments are no longer confined to the rich in metropolitan cities.
1 min
December 04, 2025
Mint Chennai
‘Targeting public debt appropriate during uncertainty’
India’s shift from targeting annual fiscal deficit to long-term debt was appropriate during a period of external economic uncertainty, chief economic adviser V. Anantha Nageswaran said.
1 mins
December 04, 2025
Mint Chennai
Services PMI rebounds in November
India’s services sector rebounded in November, as new business intakes increased amid subdued price pressures and improving demand, a private sw showed on Wednesday.
2 mins
December 04, 2025
Mint Chennai
Climate chaos: Megacities face rapidly rising risks of flooding
Urban spaces in the tropical monsoon belt are the most vulnerable
3 mins
December 04, 2025
Mint Chennai
Seeking affordable financial advice? Try fixed-fee RIAs
Sebi-registered RIAs earn from client fees, not commissions, ensuring conflict-free guidance
5 mins
December 04, 2025
Mint Chennai
IT sector sheds weight in stock market indices as AI rises
Since the start of the year, shares of the five largest firms have seen sharp drops: TCS fell by 23.47%, Infosys 17%, HCLTech 14.74%, Wipro 17.14%, and Tech Mahindra 9.97%.
2 mins
December 04, 2025
Mint Chennai
IT sheds weight in indices as AI rises
Combined weight of IT cos in BSE Sensex down to 18-year low
1 mins
December 04, 2025
Mint Chennai
JLR CEO Balaji's early trials: top exit, cyberattack impact
Gerry McGovern's abrupt removal has created uncertainty over brand and design strategy
3 mins
December 04, 2025
Mint Chennai
IndiGo flights hit by pilot rest rules, weather, leaves
DGCA probing disruption, working with IndiGo to minimize inconvenience
2 mins
December 04, 2025
Mint Chennai
Natco Pharma's cyclical model leaves revenue outlook cloudy
Shares of Natco Pharma Ltd have dropped 38% from the 52-week high of ₹1,505 (December 2024), as the Street grows cautious about its high-risk, high-reward business model.
1 mins
December 04, 2025
Listen
Translate
Change font size